Both in Biotechnology
Vir Biotechnology vs Novavax
Over the past year VIR returned +89.2% and NVAX returned +26.3%; their daily moves had a correlation of 0.38.
VIR +89.2% NVAX +26.3%Growth of $1, one year, split-adjusted
| Metric | VIR | NVAX |
|---|---|---|
| Price | $10.65 | $10.82 |
| Market cap | $1.80B | $1.78B |
| Today | +1.33% | +0.19% |
| 1 month | −1.7% | +16.8% |
| 6 months | +25.9% | +33.7% |
| Year to date | +76.6% | +61.0% |
| 1 year | +94.0% | +26.5% |
| Revenue growth (YoY) | +19582.5% | −76.3% |
| Gross margin | 100.0% | 74.9% |
| Net margin | 33.5% | −94.2% |
| P/E (TTM) | — | — |
| Price / sales | 5.9× | 4.3× |
| Net cash | $532.7M | $422.0M |
| Dividend yield | — | — |
| Volatility (60d) | 46.1% | 49.2% |
| Short % of float | 14.9% | 31.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).